Cargando…
Pharmacogenomics DNA Biomarkers in Colorectal Cancer: Current Update
Colorectal cancer (CRC) remains as one of the most common cause of worldwide cancer morbidity and mortality. Improvements in surgical modalities and adjuvant chemotherapy have increased the cure rates in early stage disease, but a significant portion of the patients will develop recurrence or advanc...
Autores principales: | Ab Mutalib, Nurul-Syakima, Md Yusof, Najwa F., Abdul, Shafina-Nadiawati, Jamal, Rahman |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5644034/ https://www.ncbi.nlm.nih.gov/pubmed/29075194 http://dx.doi.org/10.3389/fphar.2017.00736 |
Ejemplares similares
-
Molecular Characterization of Somatic Alterations in Dukes’ B and C Colorectal Cancers by Targeted Sequencing
por: Abdul, Shafina-Nadiawati, et al.
Publicado: (2017) -
Exosomes As Potential Biomarkers and Targeted Therapy in Colorectal Cancer: A Mini-Review
por: Hon, Kha Wai, et al.
Publicado: (2017) -
miRNAs and lncRNAs as Predictive Biomarkers of Response to FOLFOX Therapy in Colorectal Cancer
por: Hon, Kha Wai, et al.
Publicado: (2018) -
Identification of Predictive DNA Methylation Biomarkers for Chemotherapy Response in Colorectal Cancer
por: Baharudin, Rashidah, et al.
Publicado: (2017) -
Gene Mutations as Emerging Biomarkers and Therapeutic Targets for Relapsed Acute Myeloid Leukemia
por: Aziz, Habsah, et al.
Publicado: (2017)